World Market of Carcinoembryonic Antigen and Forecast by 2023| Broadcast MRFR

1. Carcinoembryonic Antigen Market Research Report- Global Forecast Till 2023 Global Industry Survey, Growth, Competitive Landscape and Forecasts to 2023 CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

2. Carcinoembryonic Antigen Market Research Report - Forecast to 2023 Research Across Sectors to Give Impetus to Global Carcinoembryonic Antigen Market 2023 Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations. However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA based diagnostic assays are used for the detection of such cancers and to check the treatment efficiency during the therapeutic period by a physician. In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030. This will increase the colorectal cancer diagnostic demands, thereby propelling the market growth. Increasing prevalence of cancer, rising healthcare expenditures, and developing diagnostic technologies will boost the global market during the forecast period. However, risk of infection and hematoma, lack of awareness and medical services in the developing countries will restrain the market growth during the assessment period. Browse Report Details @ https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market- 772 2 www.marketresearchfuture.com

3. Carcinoembryonic Antigen Market Research Report - Forecast to 2023 Regional Analysis: The Americas account for the largest share in the carcinoembryogenic antigen market. The Americas mainly include countries like the U.S. and Canada. Increasing prevalence of cancer and high healthcare expenditures within the region will boost the market growth over the assessment period. Europe is the second highest revenue generating region in the global carcinoembryogenic antigen market. Increasing prevalence of cancer, fast adoption of new technologies and presence of developed countries like Germany and U.K within the region will boost the market growth during the forecasted period. On account of the developing medical infrastructure, rising healthcare expenditure, and increasing government initiatives, Asia Pacific region is expected to grow the fastest. Industry Segments The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user.Based on application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others. Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others.Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others. Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/772 3 www.marketresearchfuture.com

4. Carcinoembryonic Antigen Market Research Report - Forecast to 2023 Application & Major Players in this Research: Carcinoembryonic Antigen Market Prominent Players: Some of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC. Commenting on the report, an analyst from Market Research Future (MRFR)’s team said: The competitive market is witnessing several strategies such as mergers and collaborations that could take the market forward. For instance, Illumina bought EdicoGenome, a data analysis company that provides solutions for NGS. Myriad Genetics acquired Counsyl, a specialist in carrier screening and non-invasive prenatal screening. Get Discount @ https://www.marketresearchfuture.com/check-discount/772 4 www.marketresearchfuture.com

5. Carcinoembryonic Antigen Market Research Report - Forecast to 2023 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous- Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. 5 www.marketresearchfuture.com

6. THANK YOU MARKET RESEARCH MARKET RESEARCH FUTURE FUTURE salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) 6 www.marketresearchfuture.com